Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Prevalence of and risk factors for low bone mineral density in Spanish treated HIV-infected patients.

Cervero M, Torres R, Agud JL, Alcázar V, Jusdado JJ, García-Lacalle C, Moreno S.

PLoS One. 2018 Apr 30;13(4):e0196201. doi: 10.1371/journal.pone.0196201. eCollection 2018.

2.

Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection.

Berenguer J, Rodríguez-Castellano E, Carrero A, Von Wichmann MA, Montero M, Galindo MJ, Mallolas J, Crespo M, Téllez MJ, Quereda C, Sanz J, Barros C, Tural C, Santos I, Pulido F, Guardiola JM, Rubio R, Ortega E, Montes ML, Jusdado JJ, Gaspar G, Esteban H, Bellón JM, González-García J; GESIDA HIV/HCV Cohort Study Group.

Hepatology. 2017 Aug;66(2):344-356. doi: 10.1002/hep.29071. Epub 2017 Jun 22.

3.

[Predictive factors of clinically significant drug-drug interactions among regimens based on protease inhibitors, non-nucleoside reverse transcriptase inhibitors and raltegravir].

Cervero M, Torres R, Jusdado JJ, Pastor S, Agud JL.

Med Clin (Barc). 2016 Apr 15;146(8):339-45. doi: 10.1016/j.medcli.2016.01.016. Epub 2016 Mar 11. Spanish.

PMID:
26971988
4.

[Aging and influence of inversion of the CD4:CD8 ratio in the incidence of co-morbidities and mortality in a cohort of patients infected with human immunodeficiency virus].

Cervero M, Torres R, Agud JL, Pastor S, Jusdado JJ.

Med Clin (Barc). 2016 Mar 4;146(5):189-93. doi: 10.1016/j.medcli.2015.10.014. Epub 2015 Dec 23. Spanish.

PMID:
26726112
5.

Comparison of the prognostic value of liver biopsy and FIB-4 index in patients coinfected with HIV and hepatitis C virus.

Berenguer J, Zamora FX, Aldámiz-Echevarría T, Von Wichmann MA, Crespo M, López-Aldeguer J, Carrero A, Montes M, Quereda C, Téllez MJ, Galindo MJ, Sanz J, Santos I, Guardiola JM, Barros C, Ortega E, Pulido F, Rubio R, Mallolas J, Tural C, Jusdado JJ, Pérez G, Díez C, Álvarez-Pellicer J, Esteban H, Bellón JM, González-García J; Grupo de Estudio del SIDA (GESIDA) HIV/HCV Cohort Study Group.

Clin Infect Dis. 2015 Mar 15;60(6):950-8. doi: 10.1093/cid/ciu939. Epub 2014 Nov 24.

PMID:
25422386
6.

Higher vitamin D levels in HIV-infected out-patients on treatment with boosted protease inhibitor monotherapy.

Cervero M, Agud JL, Torres R, García-Lacalle C, Alcázar V, Jusdado JJ, Moreno S.

HIV Med. 2013 Oct;14(9):556-62. doi: 10.1111/hiv.12049. Epub 2013 Jun 5.

7.

Clinical effects of viral relapse after interferon plus ribavirin in patients co-infected with human immunodeficiency virus and hepatitis C virus.

Berenguer J, Alvarez-Pellicer J, Carrero A, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Tural C, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Barquilla E, Bellón JM, González-García J; GESIDA HIV/HCV Cohort Study Group.

J Hepatol. 2013 Jun;58(6):1104-12. doi: 10.1016/j.jhep.2013.01.042. Epub 2013 Feb 7.

PMID:
23395690
8.

Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus.

Berenguer J, Rodríguez E, Miralles P, Von Wichmann MA, López-Aldeguer J, Mallolas J, Galindo MJ, Van Den Eynde E, Téllez MJ, Quereda C, Jou A, Sanz J, Barros C, Santos I, Pulido F, Guardiola JM, Ortega E, Rubio R, Jusdado JJ, Montes ML, Gaspar G, Esteban H, Bellón JM, González-García J; GESIDA HIV/HCV Cohort Study Group.

Clin Infect Dis. 2012 Sep;55(5):728-36. Epub 2012 May 18.

PMID:
22610932
9.

Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy.

Cervero M, Agud JL, García-Lacalle C, Alcázar V, Torres R, Jusdado JJ, Moreno Guillén S.

AIDS Res Hum Retroviruses. 2012 Sep;28(9):963-71. doi: 10.1089/AID.2011.0244. Epub 2012 Mar 6.

PMID:
22242918
10.

Antimicrobial treatment of invasive non-perinatal human listeriosis and the impact of the underlying disease on prognosis.

Fernández Guerrero ML, Torres R, Mancebo B, González-López JJ, Górgolas M, Jusdado JJ, Roblas RF.

Clin Microbiol Infect. 2012 Jul;18(7):690-5. doi: 10.1111/j.1469-0691.2011.03616.x. Epub 2011 Aug 18.

11.

[Efficacy and safety of a reduced-dose of stavudine in HIV-infected patients under immunological and virological stable conditions].

Pedrol E, Martín T, del Pozo MA, Flores J, Sanz J, Cartón JA, Jusdado JJ, Arazo P, Ribera E, Deig E; Grupo de Estudio de Evaluación del uso de Análogos de Nucleósidos.

Med Clin (Barc). 2007 Sep 22;129(10):361-5. Spanish.

PMID:
17915129
12.

[Immunological effectiveness of the nucleoside/nucleotide analog combinations, tenofovir + lamivudine, didanosine + lamivudine and tenofovir + didanosine, in patients with HIV infection and sustained viral suppression].

Cervero M, Torres R, Jusdado JJ, Rodríguez-Rosado R, Del Alamo M, García-Benaya E.

Enferm Infecc Microbiol Clin. 2006 Aug-Sep;24(7):426-30. Spanish.

PMID:
16956530
13.

[Analysis of hospital admittance and mortality in AIDS patients].

Cervero M, Jusdado JJ, Torres R, Solís J.

Enferm Infecc Microbiol Clin. 2004 Aug-Sep;22(7):436; author reply 436-8. Spanish. No abstract available.

PMID:
15355778
14.

Infectious endocarditis due to non-typhi Salmonella in patients infected with human immunodeficiency virus: report of two cases and review.

Fernández Guerrero ML, Torres Perea R, Gómez Rodrigo J, Núñez García A, Jusdado JJ, Ramos Rincón JM.

Clin Infect Dis. 1996 May;22(5):853-5. Review.

PMID:
8722947
15.

[Campylobacter jejuni sepsis in a patient with HIV infection and chronic hepatopathy].

Padilla B, Gómez J, Delgado-Iribarren A, Wilhelmi I, Jusdado JJ.

Enferm Infecc Microbiol Clin. 1993 Mar;11(3):166-7. Spanish. No abstract available.

PMID:
8499522

Supplemental Content

Loading ...
Support Center